ArticleExperimental and therapeutic medicine2024

Formononetin suppresses the malignant progression of papillary thyroid carcinoma depending on downregulation of CBX4.

Hongbo Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.